Drugmakers spend an average $237,000 per medical science liaison in the USA

US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but medical device companies spend around $32,000 more, according to a new study by Cutting Edge Information.

The study, “Managing Medical Science Liaison Teams: Budget, Staffing and Compensation Benchmarks,” found that most pharmaceutical country affiliates typically spend between $158,000 and $237,000 per MSL. In Japan, however, companies spend an average $307,000 per MSL. MSL spending varies between small and large companies, as well. Top 20 pharmaceutical companies, for example, spend an average $241,000 per US MSL. Medical device and diagnostic companies, however, top all other company categories, spending an average $267,000 per MSL across all countries.

MSLs vital role prior to and during product launches